nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketobemidone—CYP3A4—bone cancer	0.896	1	CbGaD
Ketobemidone—CYP2B6—Cisplatin—bone cancer	0.0227	0.416	CbGbCtD
Ketobemidone—CYP2B6—Doxorubicin—bone cancer	0.0152	0.279	CbGbCtD
Ketobemidone—CYP2C9—Cisplatin—bone cancer	0.012	0.22	CbGbCtD
Ketobemidone—CYP3A4—Doxorubicin—bone cancer	0.00467	0.0856	CbGbCtD
Ketobemidone—UGT1A9—Irinotecan Pathway—CYP3A4—bone cancer	0.00164	0.0338	CbGpPWpGaD
Ketobemidone—CYP2B6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00159	0.0328	CbGpPWpGaD
Ketobemidone—CYP2C8—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00134	0.0277	CbGpPWpGaD
Ketobemidone—UGT1A9—Estrogen metabolism—CYP3A4—bone cancer	0.00134	0.0277	CbGpPWpGaD
Ketobemidone—CYP2B6—Liver X Receptor Pathway—CYP3A4—bone cancer	0.00133	0.0275	CbGpPWpGaD
Ketobemidone—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.00128	0.0265	CbGpPWpGaD
Ketobemidone—CYP2C19—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.0012	0.0248	CbGpPWpGaD
Ketobemidone—UGT1A9—Metapathway biotransformation—CYP4V2—bone cancer	0.0011	0.0227	CbGpPWpGaD
Ketobemidone—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00109	0.0226	CbGpPWpGaD
Ketobemidone—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.00104	0.0216	CbGpPWpGaD
Ketobemidone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000857	0.0177	CbGpPWpGaD
Ketobemidone—UGT1A9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000845	0.0175	CbGpPWpGaD
Ketobemidone—OPRK1—Mecp2 and Associated Rett Syndrome—EZH2—bone cancer	0.000776	0.016	CbGpPWpGaD
Ketobemidone—Pethidine—CYP3A4—bone cancer	0.000774	1	CrCbGaD
Ketobemidone—CYP2B6—Xenobiotics—CYP3A4—bone cancer	0.000765	0.0158	CbGpPWpGaD
Ketobemidone—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000721	0.0149	CbGpPWpGaD
Ketobemidone—CYP2B6—Metapathway biotransformation—CYP4V2—bone cancer	0.000682	0.0141	CbGpPWpGaD
Ketobemidone—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000678	0.014	CbGpPWpGaD
Ketobemidone—CYP2C8—Xenobiotics—CYP3A4—bone cancer	0.000648	0.0134	CbGpPWpGaD
Ketobemidone—CYP2C8—Tamoxifen metabolism—CYP3A4—bone cancer	0.000623	0.0129	CbGpPWpGaD
Ketobemidone—UGT1A9—PPAR Alpha Pathway—CDK4—bone cancer	0.000618	0.0128	CbGpPWpGaD
Ketobemidone—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—bone cancer	0.000591	0.0122	CbGpPWpGaD
Ketobemidone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00059	0.0122	CbGpPWpGaD
Ketobemidone—CYP2C19—Xenobiotics—CYP3A4—bone cancer	0.000578	0.012	CbGpPWpGaD
Ketobemidone—CYP2C8—Metapathway biotransformation—CYP4V2—bone cancer	0.000578	0.0119	CbGpPWpGaD
Ketobemidone—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.000556	0.0115	CbGpPWpGaD
Ketobemidone—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.000527	0.0109	CbGpPWpGaD
Ketobemidone—CYP2B6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000525	0.0109	CbGpPWpGaD
Ketobemidone—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.000516	0.0107	CbGpPWpGaD
Ketobemidone—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000507	0.0105	CbGpPWpGaD
Ketobemidone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000501	0.0103	CbGpPWpGaD
Ketobemidone—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.00047	0.00972	CbGpPWpGaD
Ketobemidone—PTGS1—Overview of nanoparticle effects—PTGS2—bone cancer	0.000463	0.00957	CbGpPWpGaD
Ketobemidone—OPRD1—G alpha (i) signalling events—GRM4—bone cancer	0.000446	0.00923	CbGpPWpGaD
Ketobemidone—OPRD1—G alpha (i) signalling events—RGS1—bone cancer	0.000446	0.00923	CbGpPWpGaD
Ketobemidone—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000397	0.00821	CbGpPWpGaD
Ketobemidone—OPRK1—G alpha (i) signalling events—RGS1—bone cancer	0.000392	0.00809	CbGpPWpGaD
Ketobemidone—OPRK1—G alpha (i) signalling events—GRM4—bone cancer	0.000392	0.00809	CbGpPWpGaD
Ketobemidone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000389	0.00805	CbGpPWpGaD
Ketobemidone—PTGS1—Eicosanoid Synthesis—PTGS2—bone cancer	0.000384	0.00794	CbGpPWpGaD
Ketobemidone—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000362	0.00748	CbGpPWpGaD
Ketobemidone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000345	0.00713	CbGpPWpGaD
Ketobemidone—PTGS1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000338	0.00698	CbGpPWpGaD
Ketobemidone—OPRM1—G alpha (i) signalling events—GRM4—bone cancer	0.000331	0.00684	CbGpPWpGaD
Ketobemidone—OPRM1—G alpha (i) signalling events—RGS1—bone cancer	0.000331	0.00684	CbGpPWpGaD
Ketobemidone—UGT1A9—Phase II conjugation—GSTP1—bone cancer	0.000322	0.00665	CbGpPWpGaD
Ketobemidone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—bone cancer	0.000321	0.00664	CbGpPWpGaD
Ketobemidone—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000318	0.00657	CbGpPWpGaD
Ketobemidone—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000314	0.00648	CbGpPWpGaD
Ketobemidone—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.00031	0.00641	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—GRM4—bone cancer	0.00027	0.00559	CbGpPWpGaD
Ketobemidone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000269	0.00556	CbGpPWpGaD
Ketobemidone—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000265	0.00549	CbGpPWpGaD
Ketobemidone—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000258	0.00532	CbGpPWpGaD
Ketobemidone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000252	0.00522	CbGpPWpGaD
Ketobemidone—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00024	0.00496	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—GRM4—bone cancer	0.000237	0.0049	CbGpPWpGaD
Ketobemidone—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000237	0.0049	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—GRM1—bone cancer	0.000234	0.00484	CbGpPWpGaD
Ketobemidone—UGT1A9—Biological oxidations—CYP3A4—bone cancer	0.00022	0.00455	CbGpPWpGaD
Ketobemidone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000219	0.00452	CbGpPWpGaD
Ketobemidone—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000218	0.00451	CbGpPWpGaD
Ketobemidone—UGT1A9—Metapathway biotransformation—CYP3A4—bone cancer	0.000217	0.00448	CbGpPWpGaD
Ketobemidone—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000216	0.00447	CbGpPWpGaD
Ketobemidone—UGT1A9—NRF2 pathway—GSTP1—bone cancer	0.000215	0.00443	CbGpPWpGaD
Ketobemidone—UGT1A9—NRF2 pathway—TGFBR2—bone cancer	0.000215	0.00443	CbGpPWpGaD
Ketobemidone—PTGS1—Arachidonic acid metabolism—PTGS2—bone cancer	0.000214	0.00441	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—GRM1—bone cancer	0.000206	0.00425	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—GRM4—bone cancer	0.0002	0.00414	CbGpPWpGaD
Ketobemidone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000198	0.0041	CbGpPWpGaD
Ketobemidone—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000195	0.00402	CbGpPWpGaD
Ketobemidone—UGT1A9—Biological oxidations—GSTP1—bone cancer	0.000188	0.00389	CbGpPWpGaD
Ketobemidone—UGT1A9—Metapathway biotransformation—GSTP1—bone cancer	0.000186	0.00384	CbGpPWpGaD
Ketobemidone—PTGS1—Biological oxidations—CYP3A4—bone cancer	0.000179	0.00371	CbGpPWpGaD
Ketobemidone—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000178	0.00367	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—GRM1—bone cancer	0.000174	0.00359	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—SMO—bone cancer	0.000165	0.00341	CbGpPWpGaD
Ketobemidone—PTGS1—Biological oxidations—GSTP1—bone cancer	0.000153	0.00317	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—GRM4—bone cancer	0.000153	0.00316	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—RGS1—bone cancer	0.000153	0.00316	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—SMO—bone cancer	0.000145	0.00299	CbGpPWpGaD
Ketobemidone—OPRM1—TCR Signaling Pathway—JUN—bone cancer	0.000144	0.00298	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—GRM4—bone cancer	0.000139	0.00287	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—RGS1—bone cancer	0.000139	0.00287	CbGpPWpGaD
Ketobemidone—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	0.000138	0.00285	CbGpPWpGaD
Ketobemidone—CYP2B6—Biological oxidations—CYP3A4—bone cancer	0.000137	0.00283	CbGpPWpGaD
Ketobemidone—PTGS1—Selenium Micronutrient Network—PTGS2—bone cancer	0.000136	0.00281	CbGpPWpGaD
Ketobemidone—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	0.000135	0.00279	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—GRM4—bone cancer	0.000134	0.00277	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—RGS1—bone cancer	0.000134	0.00277	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—GRM1—bone cancer	0.000132	0.00274	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—NDUFA12—bone cancer	0.000132	0.00273	CbGpPWpGaD
Ketobemidone—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	0.000123	0.00254	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—SMO—bone cancer	0.000122	0.00253	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—RGS1—bone cancer	0.000122	0.00251	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—GRM4—bone cancer	0.000122	0.00251	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—GRM1—bone cancer	0.00012	0.00249	CbGpPWpGaD
Ketobemidone—CYP2B6—Biological oxidations—GSTP1—bone cancer	0.000117	0.00242	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—GRM1—bone cancer	0.000116	0.0024	CbGpPWpGaD
Ketobemidone—CYP2C8—Biological oxidations—CYP3A4—bone cancer	0.000116	0.00239	CbGpPWpGaD
Ketobemidone—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	0.000115	0.00239	CbGpPWpGaD
Ketobemidone—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	0.000114	0.00236	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—GRM4—bone cancer	0.000113	0.00234	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—RGS1—bone cancer	0.000113	0.00234	CbGpPWpGaD
Ketobemidone—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	0.000112	0.00232	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—NT5C3A—bone cancer	0.000109	0.00226	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—NDUFA12—bone cancer	0.000108	0.00222	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—GRM1—bone cancer	0.000105	0.00218	CbGpPWpGaD
Ketobemidone—CYP2C19—Biological oxidations—CYP3A4—bone cancer	0.000103	0.00214	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—RGS1—bone cancer	0.000103	0.00212	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—GRM4—bone cancer	0.000103	0.00212	CbGpPWpGaD
Ketobemidone—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	0.000102	0.00211	CbGpPWpGaD
Ketobemidone—CYP2C8—Biological oxidations—GSTP1—bone cancer	9.91e-05	0.00205	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—GRM1—bone cancer	9.82e-05	0.00203	CbGpPWpGaD
Ketobemidone—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	9.77e-05	0.00202	CbGpPWpGaD
Ketobemidone—CYP2C9—Biological oxidations—CYP3A4—bone cancer	9.43e-05	0.00195	CbGpPWpGaD
Ketobemidone—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	9.3e-05	0.00192	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—GRM1—bone cancer	8.91e-05	0.00184	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—NT5C3A—bone cancer	8.91e-05	0.00184	CbGpPWpGaD
Ketobemidone—CYP2C19—Biological oxidations—GSTP1—bone cancer	8.84e-05	0.00183	CbGpPWpGaD
Ketobemidone—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	8.72e-05	0.0018	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—GNA11—bone cancer	8.54e-05	0.00176	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—SMO—bone cancer	8.48e-05	0.00175	CbGpPWpGaD
Ketobemidone—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	8.21e-05	0.0017	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—NDUFA12—bone cancer	8.2e-05	0.0017	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—RGS1—bone cancer	8.2e-05	0.00169	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—GRM4—bone cancer	8.2e-05	0.00169	CbGpPWpGaD
Ketobemidone—CYP2C9—Biological oxidations—GSTP1—bone cancer	8.06e-05	0.00167	CbGpPWpGaD
Ketobemidone—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	7.95e-05	0.00164	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—GNA11—bone cancer	7.75e-05	0.0016	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—IL3—bone cancer	7.74e-05	0.0016	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—GNA11—bone cancer	7.48e-05	0.00155	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—SMO—bone cancer	7.43e-05	0.00154	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—GRM4—bone cancer	7.19e-05	0.00149	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—RGS1—bone cancer	7.19e-05	0.00149	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—GRM1—bone cancer	7.11e-05	0.00147	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—IL3—bone cancer	7.03e-05	0.00145	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—NDUFA12—bone cancer	6.94e-05	0.00144	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—GNA11—bone cancer	6.8e-05	0.0014	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—NT5C3A—bone cancer	6.8e-05	0.0014	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—IL3—bone cancer	6.79e-05	0.0014	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—GNA11—bone cancer	6.33e-05	0.00131	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—SMO—bone cancer	6.28e-05	0.0013	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—GRM1—bone cancer	6.23e-05	0.00129	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—NDUFA12—bone cancer	6.2e-05	0.00128	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—IL3—bone cancer	6.16e-05	0.00127	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—GRM4—bone cancer	6.07e-05	0.00126	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—RGS1—bone cancer	6.07e-05	0.00126	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—NT5C3A—bone cancer	5.75e-05	0.00119	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—GNA11—bone cancer	5.74e-05	0.00119	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—IL3—bone cancer	5.73e-05	0.00119	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—NDUFA12—bone cancer	5.65e-05	0.00117	CbGpPWpGaD
Ketobemidone—CYP3A4—Biological oxidations—GSTP1—bone cancer	5.32e-05	0.0011	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—GRM1—bone cancer	5.27e-05	0.00109	CbGpPWpGaD
Ketobemidone—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	5.25e-05	0.00108	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—IL3—bone cancer	5.21e-05	0.00108	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—NT5C3A—bone cancer	5.14e-05	0.00106	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—SMO—bone cancer	5.01e-05	0.00103	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—ENO2—bone cancer	4.79e-05	0.000989	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—NT5C3A—bone cancer	4.68e-05	0.000968	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—GNA11—bone cancer	4.58e-05	0.000946	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—DHFR—bone cancer	4.44e-05	0.000918	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—SMO—bone cancer	4.39e-05	0.000907	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—ATF1—bone cancer	4.26e-05	0.00088	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IL3—bone cancer	4.15e-05	0.000858	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—GNA11—bone cancer	4.15e-05	0.000858	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—GNA11—bone cancer	4.02e-05	0.00083	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—ENO2—bone cancer	3.9e-05	0.000806	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CYP3A4—bone cancer	3.76e-05	0.000778	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.74e-05	0.000774	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—ATF1—bone cancer	3.73e-05	0.000771	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—NDUFA12—bone cancer	3.73e-05	0.00077	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—SMO—bone cancer	3.71e-05	0.000767	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IL3—bone cancer	3.64e-05	0.000752	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—DHFR—bone cancer	3.62e-05	0.000748	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TGFBR2—bone cancer	3.55e-05	0.000734	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—GNA11—bone cancer	3.39e-05	0.000701	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—GNA11—bone cancer	3.38e-05	0.000699	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IGF1R—bone cancer	3.34e-05	0.00069	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—GSTP1—bone cancer	3.22e-05	0.000665	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—ATF1—bone cancer	3.15e-05	0.000652	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TGFBR2—bone cancer	3.11e-05	0.000643	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—NT5C3A—bone cancer	3.09e-05	0.000638	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IL3—bone cancer	3.08e-05	0.000636	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CYP3A4—bone cancer	3.07e-05	0.000634	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.05e-05	0.000631	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—ENO2—bone cancer	2.98e-05	0.000615	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IGF1R—bone cancer	2.93e-05	0.000605	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—DHFR—bone cancer	2.76e-05	0.000571	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TGFBR2—bone cancer	2.63e-05	0.000544	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—GSTP1—bone cancer	2.62e-05	0.000542	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GNA11—bone cancer	2.58e-05	0.000533	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ENO2—bone cancer	2.52e-05	0.000521	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IGF1R—bone cancer	2.48e-05	0.000512	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—KIT—bone cancer	2.42e-05	0.000501	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CYP3A4—bone cancer	2.34e-05	0.000484	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—DHFR—bone cancer	2.34e-05	0.000483	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—BRAF—bone cancer	2.28e-05	0.000471	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ENO2—bone cancer	2.25e-05	0.000465	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—EGFR—bone cancer	2.21e-05	0.000456	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GNA11—bone cancer	2.19e-05	0.000452	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—KIT—bone cancer	2.12e-05	0.000439	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—DHFR—bone cancer	2.09e-05	0.000431	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ENO2—bone cancer	2.05e-05	0.000424	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GSTP1—bone cancer	2e-05	0.000414	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—BRAF—bone cancer	2e-05	0.000413	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000409	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.97e-05	0.000407	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GNA11—bone cancer	1.95e-05	0.000403	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—EGFR—bone cancer	1.94e-05	0.0004	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MDM2—bone cancer	1.91e-05	0.000394	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—DHFR—bone cancer	1.9e-05	0.000393	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—KIT—bone cancer	1.8e-05	0.000371	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GNA11—bone cancer	1.78e-05	0.000368	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYP3A4—bone cancer	1.77e-05	0.000365	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.76e-05	0.000364	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GSTP1—bone cancer	1.69e-05	0.00035	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—BRAF—bone cancer	1.69e-05	0.000349	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MDM2—bone cancer	1.67e-05	0.000346	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PTGS2—bone cancer	1.67e-05	0.000345	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—JUN—bone cancer	1.66e-05	0.000343	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—EGFR—bone cancer	1.64e-05	0.000338	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MMP9—bone cancer	1.61e-05	0.000333	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYP3A4—bone cancer	1.61e-05	0.000333	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.6e-05	0.000332	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GSTP1—bone cancer	1.51e-05	0.000313	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—JUN—bone cancer	1.45e-05	0.000301	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MMP9—bone cancer	1.41e-05	0.000292	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MDM2—bone cancer	1.41e-05	0.000292	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GSTP1—bone cancer	1.38e-05	0.000285	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PTGS2—bone cancer	1.36e-05	0.000281	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ENO2—bone cancer	1.35e-05	0.00028	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—EGFR—bone cancer	1.3e-05	0.000269	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—DHFR—bone cancer	1.26e-05	0.000259	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—JUN—bone cancer	1.23e-05	0.000254	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MMP9—bone cancer	1.2e-05	0.000247	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GNA11—bone cancer	1.17e-05	0.000242	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—EGFR—bone cancer	1.14e-05	0.000236	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TP53—bone cancer	1.09e-05	0.000226	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PTGS2—bone cancer	1.04e-05	0.000214	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—EGFR—bone cancer	9.66e-06	0.0002	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TP53—bone cancer	9.6e-06	0.000198	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GSTP1—bone cancer	9.1e-06	0.000188	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PTGS2—bone cancer	8.78e-06	0.000181	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TP53—bone cancer	8.11e-06	0.000168	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PTGS2—bone cancer	7.84e-06	0.000162	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PTGS2—bone cancer	7.14e-06	0.000148	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PTGS2—bone cancer	4.71e-06	9.74e-05	CbGpPWpGaD
